These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3172555)

  • 61. Anaphylaxis in guinea pigs challenged with antivenin preparations.
    Jeter WS; Russell FE; Sullivan JB
    Toxicon; 1983; 21(5):729-30. PubMed ID: 6648986
    [No Abstract]   [Full Text] [Related]  

  • 62. ANALYSIS OF ARKANSAS SNAKEBITES.
    PARRISH HM
    J Ark Med Soc; 1964 Nov; 61():176-81. PubMed ID: 14218575
    [No Abstract]   [Full Text] [Related]  

  • 63. SNAKEBITES IN NORTHWESTERN STATES.
    PARRISH HM
    Northwest Med; 1964 Oct; 63():707-12. PubMed ID: 14201793
    [No Abstract]   [Full Text] [Related]  

  • 64. Factors associated with adverse reactions induced by caprylic acid-fractionated whole IgG preparations: comparison between horse, sheep and camel IgGs.
    Herrera M; León G; Segura A; Meneses F; Lomonte B; Chippaux JP; Gutiérrez JM
    Toxicon; 2005 Dec; 46(7):775-81. PubMed ID: 16183094
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Clinical Serum Therapy: Benefits, Cautions, and Potential Applications.
    Hifumi T; Yamamoto A; Ato M; Sawabe K; Morokuma K; Morine N; Kondo Y; Noda E; Sakai A; Takahashi J; Umezawa K
    Keio J Med; 2017 Dec; 66(4):57-64. PubMed ID: 28450682
    [TBL] [Abstract][Full Text] [Related]  

  • 66. CHARACTERISTICS OF SNAKEBITES IN MISSOURI.
    PARRISH HW
    Mo Med; 1964 Oct; 61():845-50. PubMed ID: 14217492
    [No Abstract]   [Full Text] [Related]  

  • 67. Past, present, and future immunotherapy of snake venom poisoning.
    Sullivan JB
    Ann Emerg Med; 1987 Sep; 16(9):938-44. PubMed ID: 3631680
    [TBL] [Abstract][Full Text] [Related]  

  • 68. NOTES ON NEBRASKA SNAKEBITES.
    PARRISH HM
    Nebr State Med J; 1964 Dec; 49():651-8. PubMed ID: 14224174
    [No Abstract]   [Full Text] [Related]  

  • 69. The determination of the potency of human tetanus immunoglobulins by an enzyme-linked immunosorbent assay.
    Gentili G; Pini C; Collotti C
    J Biol Stand; 1984; 12(2):167-73. PubMed ID: 6736047
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Preparation of a new antivenin by affinity chromatography.
    Russell FE; Sullivan JB; Egen NB; Jeter WS; Markland FS; Wingert WA; Bar-Or D
    Am J Trop Med Hyg; 1985 Jan; 34(1):141-50. PubMed ID: 2578749
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Donor human antidiphtheritic immunoglobulin is an alternative to xenogeneic antidiphtheritic serum].
    Fedorovskaia EA; Mel'nik EA; Lyspak SA; Agafonova VV; Kolesova TV; Borisenko AI; Skorodumova NP
    Lik Sprava; 2005 Dec; (8):74-6. PubMed ID: 16498790
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Various problems in the use of tetanus antiserum for therapeutic purposes and the mechanism of action of tetanus antitoxin].
    Kryzhanovskiĭ GN; Alekseev LP
    Zh Mikrobiol Epidemiol Immunobiol; 1969 Jan; 46(1):74-81. PubMed ID: 5787576
    [No Abstract]   [Full Text] [Related]  

  • 73. Survey of assay methods of antivenins; immunological factors influencing antivenin standardization.
    GRASSET E
    Bull World Health Organ; 1957; 16(1):79-122. PubMed ID: 13413648
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Egyptian polyvalent antisnakebite serum technic of preparation.
    Mohamed AH; Bakr IA; Kamel A
    Toxicon; 1966 Jun; 4(1):69-72. PubMed ID: 4960436
    [No Abstract]   [Full Text] [Related]  

  • 75. Snake antivenin. Effect on survival time in experimentally induced hemorrhagic pancreatitis.
    Rittenbury MS; Hanback LD
    Arch Surg; 1969 Aug; 99(2):179-84. PubMed ID: 4978522
    [No Abstract]   [Full Text] [Related]  

  • 76. Intrathecal administration of tetanus antiserum.
    Shann F
    Med J Aust; 1983 Dec 10-24; 2(12):604-5. PubMed ID: 6689441
    [No Abstract]   [Full Text] [Related]  

  • 77. Probable occurrence of IgE in the adult domestic fowl (Gallus domesticus) after horse serum stimulation.
    Burns RB; Maxwell MH
    Vet Res Commun; 1981 Sep; 5(1):67-72. PubMed ID: 7344273
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Remarks on antivenin potency estimation.
    Christensen PA
    Toxicon; 1967 Nov; 5(2):143-5. PubMed ID: 6080374
    [No Abstract]   [Full Text] [Related]  

  • 79. [Admixtures present in antitoxic horse sera and pepsin preparations].
    Trubitsina VI; Urykova VA; Chernobel' TP; Noskova VV; Panina NP
    Zh Mikrobiol Epidemiol Immunobiol; 1979 Apr; (4):95-101. PubMed ID: 87071
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [IgG4 levels in polyvalent immunoglobulins and immunoglobulins prepared by precipitation with caprylic acid].
    Lambin P; Debbia M
    Rev Fr Transfus Immunohematol; 1986; 29(5):347-53. PubMed ID: 3576044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.